Trailhead Biosystems Expands iPSC Derived Cell Portfolio with TrailBio® Endothelial Cells
April 28, 2026
iPSC-derived endothelial cells support vascular biology, drug discovery and toxicity studies BEACHWOOD, Ohio -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing human cell innovation, announces the commercial launch of TrailBio® Endothelial Cells, a functionally validated iPSC-derived model of the human vascular endothelium. Trailhead_Biosystems_Inc_Product_Data_Sheet_Image TrailBio® Endothelial Cells are differentiated from human induced pluripotent stem cells (iPSCs) [...]
April 28, 2026
Authorization expands academic and industry researcher access for LNP delivery optimization, mRNA vaccine development and gene therapy research MADISON, Wis. -- A new agreement between Promega Corporation and the RNA & Formulation Core at the University of British Columbia will enable the facility to manufacture and distribute mRNA constructs incorporating the sequence encoding NanoLuc® luciferase. This will facilitate researchers [...]
ZEISS and EDGE leverage AI to transform bioimaging in the biopharma industry
April 28, 2026
Transforming complex bioimaging data to workflows offering actionable insights for decision-making to speed up drug discovery Integrated solutions: Seamless integration of EDGE-developed quantitative assays with scalable hardware and AI-driven analytics from ZEISS to redefine bioimaging in biopharma Strategic focus: Enabling automation and enhancing decision-making through quantitative imaging, establishing an AI-native data foundation accelerating GenAI adoption Customer impact: Standardized [...]
April 28, 2026
SAN DIEGO -- Singular Genomics Systems, Inc. today announced the appointment of John Stark as Chief Executive Officer. This leadership transition comes as Singular builds on the launch of its market-leading spatial platform and enters its next phase, focused on expanding adoption, deepening strategic partnerships, and increasing the impact of multimodal spatial data across translational research, drug development, and future [...]
April 27, 2026
Supports a wide range of spectral data, including XPS, FT-IR, and NMR. From automatic determination of peak count and peak shape to background and noise estimation, AutoStatSpectra enables analysis with less dependence on individual analyst experience. TAIPEI and SINGAPORE -- a.s.ist Inc. ("a.s.ist") leverages research expertise cultivated at The University of Tokyo to drive digital transformation [...]
New iPSC Differentiation kits for neuroscience research
April 27, 2026
Amsbio has expanded its range of iPSC Differentiation Kits that provide fast and flexible generation of specific cell types without sacrificing cell purity. New to market - Quick-Glia™ product line consist of human induced pluripotent stem cell derived glial cells designed for rapid, reliable, and reproducible research in neurobiology, drug discovery, and neurodegeneration. Offering a reproducible, and scalable solution, these [...]
Astorg to Acquire Global Microbiology Business from Thermo Fisher Scientific
April 27, 2026
Luxembourg/New York/Paris – Astorg, a leading pan-European private equity firm, announces that it has signed a definitive agreement to acquire the microbiology business from Thermo Fisher Scientific (or “the Company”). Through the transaction, Thermo Fisher’s microbiology business will become an independent, privately owned platform, backed by Astorg. Building on its deep healthcare sector expertise and [...]
Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
April 27, 2026
WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides [...]
Ferrotec Introduces Ferrobeads® DNA/RNA Isolation Kits for High-Efficiency Nucleic Acid Extraction
April 27, 2026
New Ferrobeads offer Superior Binding Efficiency, Reliable Extraction and Open- Platform Flexibility LIVERMORE, Calif. -- Ferrotec (USA) Corporation, the US subsidiary of Ferrotec Corporation, a global supplier of materials, components, and precision system solutions and the leading manufacturer of magnetic liquids, today announced Ferrobeads® Quick Nucleic Acid (DNA/RNA) Isolation Kit™. For research laboratory professionals, Ferrotec's Ferrobeads offer [...]
April 27, 2026
Shimadzu Corporation has acquired a 75% stake of the outstanding shares of German startup Plasmion GmbH (headquartered in Augsburg, Bavaria) on March 23, making the company a subsidiary. This acquisition aims to obtain Plasmion’s mass spectrometer (MS) ion source technology SICRIT(Soft Ionization by Chemical Reaction In Transfer)※ and related technologies to strengthen Shimadzu’s MS business. SICRIT [...]

